FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Rinvoq 45 mg modified release tablet
Rinvoq 45 mg modified release tablet, 28, blister pack
Rinvoq 45 mg modified release tablet, 7, blister pack
Ronapreve (1 x Casirivimab (Roche) 2.5 mL vial, 1 x Imdevimab (Roche) 2.5 mL vial), 1 pack
Ronapreve Multidose (1 x Casirivimab (Roche) 11.1 mL vial, 1 x Imdevimab (Roche) 11.1 mL vial), 1 pack
Rozlytrek 100 mg capsule
Rozlytrek 100 mg capsule, 30, bottle
Rozlytrek 200 mg capsule
Rozlytrek 200 mg capsule, 90, bottle
Rukobia 600 mg modified release tablet
Rukobia 600 mg modified release tablet, 60, bottle
Ruzurgi 10 mg tablet
Ruzurgi 10 mg tablet, 100, bottle
Rybrevant 350 mg/7 mL injection, 7 mL vial
Rybrevant 350 mg/7 mL injection, 7 mL vial
Rydapt 25 mg capsule
Rydapt 25 mg capsule, 112, blister pack
Rydapt 25 mg capsule, 56, blister pack
Ryeqo 40/1/0.5 tablet
Ryeqo 40/1/0.5 tablet, 28, bottle
Ryeqo 40/1/0.5 tablet, 3 x 28, bottles
Saphnelo 300 mg/2 mL injection, 2 mL vial
Saphnelo 300 mg/2 mL injection, 2 mL vial
Sarclisa 100 mg/5 mL injection, 5 mL vial
Sarclisa 100 mg/5 mL injection, 3 x 5 mL vials
Sarclisa 100 mg/5 mL injection, 5 mL vial
Sarclisa 500 mg/25 mL injection, 1 x 25 mL vial
Sarclisa 500 mg/25 mL injection, 25 mL vial
Scemblix 20 mg tablet
Scemblix 20 mg tablet, 20, blister pack
Scemblix 20 mg tablet, 60, blister pack
Scemblix 40 mg tablet
Scemblix 40 mg tablet, 20, blister pack
Scemblix 40 mg tablet, 60, blister pack
Scenesse 16 mg implant
Scenesse 16 mg implant, 1, vial
Segluromet 2.5/1000 tablet
Segluromet 2.5/1000 tablet, 14, blister pack
Segluromet 2.5/1000 (ertugliflozin 2.5 mg + metformin hydrochloride 1 g) tablet, 56 tablets, blister pack (containered trade product pack)
Segluromet 2.5/500 tablet
Segluromet 2.5/500 tablet, 14, blister pack
Segluromet 2.5/500 tablet, 56, blister pack
Segluromet 7.5/1000 tablet
Segluromet 7.5/1000 tablet, 14, blister pack
Segluromet 7.5/1000 tablet, 56, blister pack
Segluromet 7.5/500 tablet
Segluromet 7.5/500 tablet, 14, blister pack
Segluromet 7.5/500 tablet, 56, blister pack
Shingrix (1 x vaccine vial, 1 x 0.5 mL inert diluent vial), 1 pack
Shingrix (10 x vaccine vials, 10 x 0.5 mL inert diluent vials), 1 pack
Shingrix (inert substance) diluent, 0.5 mL vial
Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial
Skyrizi 150 mg/mL injection, 1 mL pen device
Skyrizi 150 mg/mL injection, 1 mL syringe
Skyrizi 150 mg/mL injection, 1 mL pen device
Skyrizi 150 mg/mL injection, 1 mL syringe
Skyrizi 75 mg/0.83 mL injection, 0.83 mL syringe
Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes
Sogroya 10 mg/1.5 mL injection, 1.5 mL pen device
Sogroya 10 mg/1.5 mL injection, 1.5 mL pen device
Sogroya 10 mg/1.5 mL injection, 5 x 1.5 mL pen devices
Sotyktu 6 mg tablet
Sotyktu 6 mg tablet, 28, blister pack
Sotyktu 6 mg tablet, 7, blister pack
Spikevax Bivalent Original/Omicron BA.4-5 injection, 0.5 mL syringe
Spikevax Bivalent Original/Omicron BA.4-5 injection, 10 x 0.5 mL syringes
Spikevax Bivalent Original/Omicron BA.4-5 Multidose injection, 10 x 2.5 mL vials
Spikevax Bivalent Original/Omicron BA.4-5 Multidose injection, 2.5 mL vial
Spikevax Bivalent Original/Omicron Multidose injection, 10 x 2.5 mL vials
Spikevax Bivalent Original/Omicron Multidose injection, 10 x 5 mL vials
Spikevax Bivalent Original/Omicron Multidose injection, 2.5 mL vial
Spikevax Bivalent Original/Omicron Multidose injection, 5 mL vial
Spikevax Multidose 100 microgram/mL injection, 10 x 2.5 mL vials
Spikevax Multidose 100 microgram/mL injection, 2.5 mL vial
Spravato 28 mg/2 actuations nasal spray, 2 actuations, pump pack
Spravato 28 mg/2 actuations nasal spray, 2 x 2 actuations, pump packs
Spravato 28 mg/2 actuations nasal spray, 3 x 2 actuations, pump packs
Spravato 28 mg/2 actuations nasal spray, actuation
Staquis 2% ointment
Staquis 2% ointment, 100 g, tube
Staquis 2% ointment, 2.5 g, tube
Staquis 2% ointment, 30 g, tube
Staquis 2% ointment, 6 x 2.5 g, tubes
Staquis 2% ointment, 60 g, tube
Steglatro 15 mg tablet
Steglatro 15 mg tablet, 28, blister pack
Steglatro 15 mg tablet, 7, blister pack
Steglatro 5 mg tablet
Steglatro 5 mg tablet, 28, blister pack
Steglatro 5 mg tablet, 7, blister pack
Steglujan 15/100 tablet
Steglujan 15/100 tablet, 28, blister pack
Steglujan 15/100 tablet, 7, blister pack
Steglujan 5/100 tablet
Steglujan 5/100 tablet, 28, blister pack
Steglujan 5/100 tablet, 7, blister pack
Sunlenca 300 mg tablet
Sunlenca 300 mg tablet, 5, blister pack
Sunlenca 463.5 mg/1.5 mL injection, 1.5 mL vial
Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials
Symdeko (ivacaftor 150 mg + tezacaftor 100 mg) tablet

Start Previous Page 11 of 15 Next End


Reference Sets

Reference set descriptor

Back to Start